Key Takeaways
- • NYU Stern's Center for Business & Human Rights released a report documenting private equity's impact on healthcare quality, linking PE ownership to hospital closures, staffing reductions, and compromised services, while acknowledging PE provides capital and strategic value when managed responsibly.
- • Private equity has deployed over $1 trillion in debt-financed healthcare deals over the past decade, with PE-backed companies carrying average debt-to-cash flow ratios of 7.1—well above the 4.0 threshold regulators consider high and significantly above public healthcare companies' 3.0 average.
- • Between 2023 and mid-2024, 26 large PE-backed healthcare companies filed for bankruptcy; including smaller entities, 34 PE portfolio companies in healthcare went bankrupt in 2023, demonstrating elevated financial instability in the sector.
- • PE acquisition structures, particularly sale-leaseback arrangements where companies sell owned assets and lease them back, create additional financial pressure and often trigger staff reductions that directly compromise patient care quality, according to the report's lead author Michael Goldhaber, senior research scholar at NYU Stern.
- • The report calls for PE reform rather than elimination from healthcare, recommending regulatory changes to address structural vulnerabilities inherent to leveraged buyout models while preserving legitimate capital contributions to the sector.
Summary
A comprehensive report from NYU Stern's Center for Business & Human Rights has outlined systemic risks posed by private equity ownership in the healthcare sector, calling for targeted regulatory reforms to protect care quality and financial stability. The report, authored by Michael Goldhaber, senior research scholar at NYU Stern's values-based investing program, documents a decade-long pattern of deterioration in healthcare outcomes linked to PE acquisition structures, while acknowledging that private equity can provide genuine capital and strategic benefits when appropriately governed.
Private equity's footprint in healthcare has expanded dramatically. Over the past decade, PE firms have committed more than $1 trillion in debt-financed healthcare deals, establishing themselves as substantial market participants. However, the report identifies a critical structural problem: PE-backed healthcare companies operate with average debt-to-cash flow ratios of 7.1, substantially exceeding the 4.0 threshold that financial regulators designate as high-risk. By comparison, publicly traded healthcare companies maintain ratios averaging 3.0—indicating PE-backed entities carry leverage levels 57% higher than public peers, creating acute vulnerability to economic disruption.
Bankruptcy data underscore this financial stress. Between 2023 and mid-2024, 26 large PE-backed healthcare entities filed for bankruptcy. When including smaller portfolio companies, the 2023 figure reached 34 PE-backed healthcare bankruptcies, signaling systemic insolvency risk within the PE healthcare portfolio. These failures have cascading effects: hospital closures eliminate care access, particularly in rural and underserved communities, while reduced staffing directly compromises treatment quality and safety.
A predominant PE strategy exacerbating financial strain involves sale-leaseback transactions, wherein PE-backed healthcare operators sell owned facilities and subsequently lease them back. This structure extracts cash for debt service and distributions to PE sponsors while burdening underlying healthcare providers with inflexible rental obligations and reduced capital for operations and staffing. Goldhaber emphasized the acute danger: "In the healthcare sector, slashing staff can be fatal. It can be a killer, simple as that." This dynamic distinguishes healthcare from other PE portfolio sectors, where cost-cutting may reduce competitiveness but does not directly jeopardize human life.
The report's conclusion rejects sector elimination but demands structural reform. PE investment can provide legitimate capital infusion and operational expertise; however, the current regulatory environment permits excessive value extraction while operators remain encumbered with unsustainable debt burdens. The NYU Stern analysis calls for reforms addressing leverage ceilings, deal structure constraints, and stakeholder protections specific to healthcare's essential infrastructure role.
Private equity's footprint in healthcare has expanded dramatically. Over the past decade, PE firms have committed more than $1 trillion in debt-financed healthcare deals, establishing themselves as substantial market participants. However, the report identifies a critical structural problem: PE-backed healthcare companies operate with average debt-to-cash flow ratios of 7.1, substantially exceeding the 4.0 threshold that financial regulators designate as high-risk. By comparison, publicly traded healthcare companies maintain ratios averaging 3.0—indicating PE-backed entities carry leverage levels 57% higher than public peers, creating acute vulnerability to economic disruption.
Bankruptcy data underscore this financial stress. Between 2023 and mid-2024, 26 large PE-backed healthcare entities filed for bankruptcy. When including smaller portfolio companies, the 2023 figure reached 34 PE-backed healthcare bankruptcies, signaling systemic insolvency risk within the PE healthcare portfolio. These failures have cascading effects: hospital closures eliminate care access, particularly in rural and underserved communities, while reduced staffing directly compromises treatment quality and safety.
A predominant PE strategy exacerbating financial strain involves sale-leaseback transactions, wherein PE-backed healthcare operators sell owned facilities and subsequently lease them back. This structure extracts cash for debt service and distributions to PE sponsors while burdening underlying healthcare providers with inflexible rental obligations and reduced capital for operations and staffing. Goldhaber emphasized the acute danger: "In the healthcare sector, slashing staff can be fatal. It can be a killer, simple as that." This dynamic distinguishes healthcare from other PE portfolio sectors, where cost-cutting may reduce competitiveness but does not directly jeopardize human life.
The report's conclusion rejects sector elimination but demands structural reform. PE investment can provide legitimate capital infusion and operational expertise; however, the current regulatory environment permits excessive value extraction while operators remain encumbered with unsustainable debt burdens. The NYU Stern analysis calls for reforms addressing leverage ceilings, deal structure constraints, and stakeholder protections specific to healthcare's essential infrastructure role.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.